Citations

Clear

17 citation(s) found for "Patel, Bhavesh M".

Normothermic Machine Perfusion, Patient-Centered Recovery, and Graft Survival After Donation-After-Circulatory-Death Liver Transplantation
Frasco, Peter E. , Mathur, Amit K, Zhang, Nan , Brennan, Bayley, Jadlowiec, Caroline, Milam, Adam J, Nguyen, Michelle K, Fah, Megan, Patel, Bhavesh M, Bettini, Layne M, Dholakia, Ruchita, Borah, Bijan, Barnhill, Michele , Aqel, Bashar, Jadlowiec, Caroline C. , Bettini, Layne M., Borah, Bijan J. , Barnhill, Michele

Mayo Clinic

Journal of the American College of Surgeons | September 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/xcs.0000000000002226 | PMID 42770976 Get It

Background: Normothermic machine perfusion (NMP) may reduce preservation injury in donation-after-circulatory-death (DCD) liver transplantation, but its association with patient-centered recovery and longer-term graft survival remains uncertain. Study Design: We retrospectively analyzed 306 consecutive adult DCD liver transplant recipients at a single center from January 2019 through December 2022, comparing NMP (n=95) with static cold storage (SCS; n=211). The primary endpoint was days alive and out of hospital at 365 days (DAOH365). Quasi-Poisson regression evaluated factors associated with DAOH365, and Cox regression evaluated graft survival. Propensity-matched and calendar-year sensitivity analyses assessed measured confounding. Results: Median DAOH365 was 357.0 (352.0, 360.0) days with NMP versus 353.0 (336.0, 359.0) with SCS (p<0.001), but preservation strategy was not independently associated with DAOH365 (adjusted rate ratio 1.02; p=0.331). NMP recipients had less early allograft dysfunction (35.8% vs 59.7%; p<0.001), ischemic cholangiopathy (4.2% vs 23.7%; p<0.001), and retransplantation within 2 years (0.0% vs 6.6%; p=0.007). Two-year patient survival did not differ significantly. NMP was associated with improved twoF-year graft survival (HR 2.9, 95% CI 1.23–6.87; p=0.015), an association maintained in propensity-matched and calendar-year sensitivity analyses. Adjusted total 1-year costs did not differ (p=0.512). Conclusions: In this single-center DCD cohort, NMP was associated with superior 2-year graft survival but not independently with DAOH365. These hypothesis-generating findings support multicenter prospective evaluation of NMP using both graft survival and patient-centered recovery endpoints.
Extracorporeal Membrane Oxygenation for Pneumocystis Pneumonia: Outcomes in Patients From the Extracorporeal Life Support Organization
Henry, Kyle J., Ham, Kealy, Cartin-Ceba, Rodrigo, Khattar, Georges , D’Cunha, Jonathan, Sen, Ayan, Patel, Bhavesh, Pulsipher, Aaron M. , Thompson, Emily , Thompson, Emily R , D'Cunha, Jonathan, Pulsipher, Aaron M , Thompson, Emily R., Vikram, Holenarasipur R. , Cartin‐Ceba, Rodrigo , Limper, Andrew H.

Mayo Clinic

Critical Care Explorations | May 5, 2026 | Volume: 8 | Issue: 5 | Pages: e1414

10.1097/cce.0000000000001414 | PMID 42084230 Get It

OBJECTIVES: Pneumocystis jirovecii pneumonia (PCP) can cause severe hypoxemic respiratory failure in immunocompromised patients. Contemporary outcomes of venovenous extracorporeal membrane oxygenation (VV ECMO) support for PCP are poorly characterized, and existing reports are limited to small case series. DESIGN: Retrospective cohort study. SETTING: International registry study using the Extracorporeal Life Support Organization (ELSO) registry. PATIENTS/SUBJECTS: Adults with PCP-associated hypoxemic respiratory failure supported with VV ECMO between 2011 and 2024. INTERVENTIONS: VV ECMO. MEASUREMENTS AND MAIN RESULTS: A total of 209 patients with PCP-associated respiratory failure supported with VV ECMO were identified. The overall in-hospital mortality was 60.8%. Survivors were younger than nonsurvivors (median age 41.9 vs. 46.8 yr; p = 0.047). Duration of mechanical ventilation before VV ECMO was longer among nonsurvivors (median 4.7 vs. 1.6 d; p = 0.019). The proportion of patients with HIV infection was similar among survivors and nonsurvivors (19.5% vs. 22.1%; p = 0.73). Pre-ECMO vasopressor use, prone positioning, and renal replacement therapy were common and did not differ between groups. Clinical course was characterized by prolonged VV ECMO support (median 18.6 d) and frequent complications, including pneumothorax (21.1%), renal replacement therapy during VV ECMO (31.6%), intracranial hemorrhage or stroke (7.7%), and major pulmonary or gastrointestinal hemorrhage (16.8%). PCP accounted for a small proportion of VV ECMO runs reported to the ELSO registry throughout the study period at 0.36% of reported cases. No significant temporal trend in mortality was observed. CONCLUSIONS: PCP-associated respiratory failure supported with VV ECMO is associated with substantial mortality and prolonged VV ECMO support. These findings provide contemporary benchmarks that may inform VV ECMO candidacy discussions and expectations in this challenging patient population.
Military-Civilian Partnership to Advance Standards of Performance for Simulated Combat Trauma Medical Skills: Validation of Competency Thresholds
Patel, B. M. , Nicholson, Susannah E. , Okerman, Tiffany S., Lopreiato, Joseph , Tisherman, S A, Frisch, Adam, Noël, P., Poropatich, Ronald , Phrampus, Paul E., Andreatta, Pamela , Athale, Janhave, Bacik, Adam , Jonas, Rachelle B., Brand, Shari, Bowyer, Mark, Butterfield, Duke, Callisen, Hannelisa, Connacher, Hugh, Chung, Yvonne, Colquist, Julie, Davisson, Blake, Gerhardus, Christian , Fitzgerald, Lavana, Phrampus, Paul, Hendrix, Cheralyn, Janicki, Adam, Knott, Camilla, Kunze, Katie, Lopreiato, Joseph, Low, Amy, McLeish, William, McQuillan, Karen , Milaski, Jessie, Mushaben, Mallory, Neustein, Benjamin, Nicholson, Susannah , Okerman, Tiffany, Patel, Bhavesh, Peterson, Paul, Proctor, Jasmine, Puche, Adam, Rorabeck, Janice, Sen, Ayan, Seamans, David, Shusko, Alexander, Sisson, Craig, Skolnick, Aaron, Sorto, Sharon, Tetzlaff, Elizabeth, Tillman, George, Tisherman, Sam, Patel, Bhavesh M , Noël, Pierre, Noel, Pierre, Andreatta, Pamela , Callisen, Hannelisa, Colquist, Julie , Knott, Camilla C., McLeish, William, Noel, Pierre, Rorabeck, Janice Annette, Shusko, Alexander , Thurman, Paul , Tisherman, Samuel A., Yu, Soojie

Mayo Clinic

Military Medicine | February 28, 2026 | Volume: 191 | Issue: Supplement_1 | Pages: 435-443

10.1093/milmed/usag118 | PMID 42560252 Get It

Abstract Introduction Combat casualty care requires standardized proficiency criteria to ensure readiness in austere environments, yet gaps persist in defining performance thresholds for critical trauma skills. The Combat Medical Skills Sustainment Consortium (CMSSC), a novel military-civilian collaboration, aimed to validate competency thresholds for 21 Department of Defense-identified trauma skills. Materials and Methods A prospective cohort study (2022-2025) enrolled 1,495 military and civilian personnel across five academic centers, stratified by experience (novice, intermediate, expert). Skills, including cricothyroidotomy, whole blood transfusion, and ultrasound-guided vascular access, were assessed using validated checklists in Role 2-congruent simulations. Statistical analysis compared checklist performance against participant experience with a priori checklist scores estimated at 40% (novices) and 90% (experts). Results Competency thresholds were established, ranging from 77% (mechanical ventilation) to 100% (handoff). Experts achieved 85%-98% proficiency across most skills, with novices at 34%-97%. A ceiling effect was observed for less complex skills consistent with the power law of practice. Conclusion The Combat Medical Skills Sustainment Consortium validated standardized assessment tools, with potential to address readiness gaps through military-civilian synergy. Findings support consortium-guided curriculum development and highlight the need for longitudinal skill decay studies. Impact This study sets a benchmark for trauma care skills assessment, facilitating rapid adoption across military and civilian settings.
EACTS Expert Consensus Document on protected cardiac surgery: pre-emptive use of temporary mechanical circulatory support in adult cardiac surgery patients at high risk for perioperative low cardiac output syndrome
Lorusso, Roberto , Salazar, Leonardo , Nersesian, Gaik , Wiedemann, Dominik , Goldstein, Daniel, Soltesz, Edward G. , Bermúdez, C. , Haft, Jonathan W., Patel, Bhavesh , Moreno, Pedro , Tonna, Joseph E. , Lamarche, Yoan , Rao, V., Meyns, Bart , Takeda, Koji , Whitman, Glenn, Potapov, Evgenij, Group, EACTS Scientific Document, Sartipy, Ulrik , Fux, Thomas , Turina, Marko , Morshuis, Michiel , Knosalla, Christoph , Milojevic, Milan , Zimpfer, Daniel , Wiedemann, Dominik , Takayama, Hiroo , Rao, Vivek , Meyns, Bart , Potapov, Evgenij , Tonna, Joseph E. , Lorusso, Roberto , Schmack, Bastian , Engelman, Daniel T. , Stein, Louis H. , Silvestry, Scott , Zimpfer, Daniel , Moreno, Pedro , MacLaren, Graeme , Takayama, Hiroo , Färber, Gloria , Boeken, Udo , Arora, Rakesh C. , Group, EACTS Scientific Document, Russo, Claudio , Meineri, Massimiliano , Paparella, Domenico

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | October 2, 2025 | Volume: 68 | Issue: 3 | Pages: No page available

10.1093/ejcts/ezaf296 | PMID 41063414 Get It

Abstract Perioperative low cardiac output syndrome (LCOS) remains a significant complication in adult cardiac surgery, contributing to substantial morbidity, prolonged intensive care, and increased mortality. Its incidence is expected to rise further due to the evolving complexity of referred surgical patients, often characterised by advanced age, multiple comorbidities, challenging anatomy, and impaired haemodynamics. Despite advances in pharmacological and perioperative care, outcomes for high-risk patients have not shown significant improvement, prompting interest in temporary mechanical circulatory support (tMCS) as a proactive strategy. This Expert Consensus Document from the European Association for Cardio-Thoracic Surgery (EACTS) presents the first dedicated guidance on the pre-emptive use of tMCS in high-risk adult cardiac surgical patients. Developed by a multidisciplinary task force, it emphasises structured risk stratification, early initiation, and individualised device management informed by interdisciplinary Heart Team discussions. The document proposes clinical pathways for patient selection, defines criteria for tMCS initiation, and provides practical algorithms for various scenarios, including advanced heart failure, cardiogenic shock, and post-cardiotomy LCOS. It reviews the current evidence on available tMCS devices, such as intra-aortic balloon pumps, microaxial flow pumps, veno-arterial extracorporeal life support and hybrid strategies, and addresses perioperative care, intensive care unit protocols, ethical considerations, as well as informed consent and support withdrawal. Despite promising results, substantial knowledge gaps remain, including long-term outcome data, device selection criteria, and cost-effectiveness analyses. This consensus aims to support clinical decision-making, standardise practice, and stimulate research to improve outcomes in a growing population of high-risk surgical patients.
Efficacy of Portable Fugitive Aerosol Mitigation Systems for Nebulizer Therapy During High-Flow Nasal Cannula and Non-Invasive Ventilation
Pandian, Adithya Shyamala , Patel, B. M. , Karam, Karam Abi , Lowell, Amelia , McKay, Kelly, Hota, Piyush , Pyznar, Gabriel , Batchelor, Sandra, Peworski, Charles, Rivas, David A., Sanghavi, Devang , Nguyen, Ngan Anh, Eltantawy, Aliaa, Li, Xueqi , Serhan, Michael , Forzani, Erica , Patel, Bhavesh M , Mora, Sabrina , Batchelor, Sandra, Peworski, Charles, Rivas, David, Xian, Xiaojun

Mayo Clinic

Emergency Care and Medicine | July 29, 2025 | Volume: 2 | Issue: 3 | Pages: 36

10.3390/ecm2030036 Get It

Objectives: This study evaluates the efficacy of existing and new aerosol mitigation methods during nebulization (Neb) in combination with high-flow nasal cannula (HFNC) oxygen supplementation and non-invasive ventilation (NIV). Methods: We recorded fugitive aerosol particle concentrations over time and assessed the peak (P) and area (A) efficacy of active and passive mitigation methods, comparing them to a no-mitigation condition. Peak efficacy was measured by the reduction in maximum aerosol concentration, while area efficacy was quantified by the reduction of the area under the aerosol concentration–time curve. Results: For HFNC with Neb, we found that active mitigation using a mask with a biofilter and a fan (referred to as the aerosol barrier mask) significantly outperformed passive mitigation with a face mask. The peak and area efficacy for aerosol reduction were 99.0% and 96.4% for active mitigation and 35.9% and 7.6% for passive mitigation, respectively. For NIV with Neb, the active mitigation method, using a box with a biofilter and fan, also outperformed passive mitigation using only the box. The peak and area efficacy for aerosol reduction were 92.1% and 85.5% for active mitigation and 53.7.0% and 25.4% for passive mitigation, respectively. Conclusion: We concluded that active mitigation set up systems advantageous for effective reduction of airborne aerosols during aerosol generated procedures.
From door to diagnosis: A case report of a rare and life-threatening presentation of Takayasu arteritis
Habib, Eiad , Macphee, Laura, Patel, Bhavesh , Sen, Ayan , LeMond, Lisa , Soh, Ina , Marshall, Chelsea, Grill, Marie , Mangipudi, Kartik, McBride, Nolan, Sekiguchi, Hiroshi, Aslam, Fawad , Marshall, Chelsea, Sekiguchi, Hiroshi

Mayo Clinic

Sage Open Medical Case Reports | April 29, 2025 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/2050313x251335205 | PMID 40308380 Get It

Takayasu arteritis is a chronic, large vessel vasculitis that typically affects the aorta and its main branches. We present a case of a 33-year-old male patient who was diagnosed with Takayasu arteritis after being admitted for acute cardiogenic shock requiring inotropes. Initial transthoracic echocardiography demonstrated severe biventricular dysfunction. Computed tomography imaging of his chest showed pulmonary infarcts. Patient subsequently developed sudden lower extremity weakness and bowel incontinence, and urgent magnetic resonance imaging of his spine demonstrated thoracolumbar vascular myelopathy. Transesophageal echocardiography revealed diffuse symmetrical thickening of the walls of the aorta; findings suggestive of aortitis. Patient was initiated on intravenous corticosteroid and systemic anticoagulation. Subsequent computed tomography angiography demonstrated irregular luminal contour of the aortic arch, and complete occlusion of the left subclavian artery, abdominal aorta, superior mesenteric artery, and left renal artery. He underwent an emergent aortoiliac thrombectomy. He was transitioned to oral prednisone, tocilizumab, and azathioprine with excellent recovery.
Abstract 4146803: Long-term outcomes of Abnormal Global Longitudinal Left Ventricular Strain during Sepsis: A propensity-matched cohort study
Jonna, Sadhana , Raavi, Lekhya , Hanson, Abby , Jena, Anek , Saleem, Faiz , Caples, Sean M., Khan, Syed Anjum , Jain, Nitesh , Cartin‐Ceba, Rodrigo , Patel, Bhavesh, Venegas, Carla , Shapiro, Anna B, Kiley, Sean , Quiñones, Quintin J., Patel, Neal M. , Sanghavi, Devang , Huespe, Iván , Isha, Shahin , Jenkins, Anna , Balavenkataraman, Arvind , Tekin, Aysun , Bansal, Vikas , Patel, Bhavesh, Milian, Ricardo Diaz , Bhattacharyya, Anirban , Chaudhary, Sanjay , Guru, Pramod , Franco, Pablo Moreno

Mayo Clinic

Circulation | November 14, 2024 | Volume: 150 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.150.suppl_1.4146803 Get It

Introduction/Background: Patients admitted with sepsis are at risk of developing septic cardiomyopathy (SCM), which may elevate their risk of short-term mortality. However, the effect of SCM on long-term outcomes after sepsis is poorly understood. This study explores whether patients with sepsis and SCM have worse long-term outcomes compared to those without SCM. Research Questions/Hypothesis: What are the long-term major adverse cardiovascular events, including death, stroke, and myocardial infarction (MACE) 36 months after ICU discharge for septic patients with abnormal global left ventricular strain (LV GLS)? Methods: We conducted a retrospective study of 396 sepsis patients from August 2018 to September 2022, approved by the Mayo Clinic IRB. Patient demographics, comorbidities, echo parameters, and outcomes were collected. Due to the expected non-linear relation between LV GLS and Hazard Ratio (HR) of MACE we employed Cox regression analysis with Restricted Cubic Splines. Secondly, we divided the population into 2 groups, patients with and without normal LV GLS (between -23 and -16). The effect of non-normal LV GLS on MACE was evaluated using Cox regression weight by inverse probability weighting (IPWT) analysis after propensity score assessment, adjusting for diabetes, hypertension, BMI, history of stroke or myocardial infarction, chronic kidney disease, age, and sex. Results: Demographic variables did not differ significantly based on normal versus abnormal LV GLS. In the restricted cox regression with cubic spline models, we observed that patients with normal values had HR lower than one compared with patients without normal values (Figure 1). Secondly, we found that the HR of MACE in patients with normal LV GLS was significantly lower in the crude analysis (HR 0.66 [CI 95% 0.5, 0.86]; p<0.01) and in the analysis adjusted by IPWT (HR 0.7 [CI 95% 0.53, 0.92]; p=0.01). Conclusion: Sepsis patients with abnormal global left ventricular strain (LV GLS) have a higher risk of major adverse cardiovascular events (MACE) within 36 months post-ICU discharge compared to those with normal strain. LV GLS values outside the range of -23 to -16 are associated with increased risk. Monitoring LV GLS in sepsis patients is important for identifying those at elevated risk for long-term cardiovascular complications.
Successful monitoring and treatment of neurotoxicity in a patient treated with CAR-T-cell therapy enhanced by ocular ultrasound (P3.9-022)
Knox, Molly, Grill, Marie , Mrugała, Maciej M. , Goodman, Brent P., Valencia-Sánchez, Cristina , Knox, Molly, Patel, Bhavesh, Castro, Januario E. , Rosenthal, Allison

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p3.9-022 Get It

Use of peripherally inserted central catheters with a dedicated vascular access specialists team versus centrally inserted central catheters in the management of septic shock patients in the ICU
Raza, Hassan , Nokes, Brandon , Concejo, Bruno Álvarez , Colquist, Julie , Patel, B. M. , Cartin‐Ceba, Rodrigo , Nokes, Brandon T , Park, John , Patel, Bhavesh M , Park, John, Kashyap, Rahul

Mayo Clinic

The Journal of Vascular Access | June 10, 2022 | Volume: 25 | Issue: 1 | Pages: 218-224

10.1177/11297298221105323 | PMID 35686502 Get It

Objectives: Peripherally inserted central catheters (PICCs) are increasingly recognized as an alternative to centrally inserted central catheters (CICCs) in critical care, yet the data regarding the safety and feasibility of this choice in septic shock management is growing but still lacking. In this study, we aimed to determine the feasibility, safety, and impact on outcomes of using dedicated vascular access specialist (VAS) teams to insert PICCs versus CICCs on patients admitted to the ICU with septic shock. Design: Retrospective cohort study. Setting: Mayo Clinic Rochester Medical ICU and Mayo Clinic Arizona Multidisciplinary ICU from 2013 to 2016. Patients: All adult patients hospitalized with diagnosis of septic shock excluding patients who declined authorization for review of their medical records, mixed shock states, and readmissions. Interventions: None. Measurement and main results: Comprehensive data regarding septic shock diagnosis and resuscitation were abstracted from electronic medical records. A total of 562 patients with septic shock were included in the study; 215 patients were resuscitated utilizing a PICC and 347 were resuscitated using a CICC. On univariate analysis, the time to central line insertion and time to vasopressor initiation were found to be reduced in those who received PICC at time of ICU admission versus CICC. Other favorable outcomes were also observed in those who received PICC versus CICC including shorter ICU length of stay and lower unadjusted hospital mortality. A multivariable analysis for hospital mortality showed that after adjusting for important covariates, neither the time to central line insertion nor the time to vasopressor initiation was associated with a lower hospital mortality. Conclusions: Across two tertiary referral centers within the same enterprise, use of a dedicated VAS team for insertion of PICCs for initial resuscitation in patients with septic shock was feasible and associated with shorter time to central venous access and initiation of vasopressors; however, adjusted hospital mortality was not different between the two groups.